Clinical Trial Update: Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and effectiveness of PDA002, a placenta-derived cell product, in subjects with Peripheral Arterial Disease and Diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer
• Peripheral Arterial Disease

Drugs mentioned

• PDA002

Snippet

Sponsor: Celularity Incorporated | Conditions: Peripheral Arterial Disease, Diabetic Foot | Phase 1 | Status: COMPLETED